Tag: ASCLEPIOS

No new safety signals in ofatumumab open-label data

Trial
ALITHIOS, ASCLEPIOS I, ASCLEPIOS II, APLIOS
Conference
MS Virtual 2020
Type
Peer-reviewed article

25 November 2020 16:57

Two trials comparing relapsing MS treatments

Presented By
Dr L. Kappos & Dr T. Sprenger
Trial
Phase 3, OPTIMUM, ASCLEPIOS
Conference
EAN 2020
Type
Peer-reviewed article

10 September 2020 12:21

Late-breaking: Ofatumumab versus teriflunomide in relapsing MS

Trial
Phase 3, ASCLEPIOS
Conference
ECTRIMS 2019
Type
Peer-reviewed article

8 November 2019 12:08
site created by:   

© 2024 Medicom Medical Publishers.  All rights reserved. Terms and Conditions | Privacy Policy



HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com